Test | Pre-SARMs | Last day SARMs usage | Post-SARMs | |
---|---|---|---|---|
8/12/2020 | 8/05/2022 | 8/29/2022 | 9/26/2022 | |
AST | 26 (0–39 U/L) | 75 (10–40 U/L) | 54 (10–40 U/L) | 29 (10–40 U/L) |
ALT | 30 (0–55 U/L) | 144 (9–46 U/L) | 120 (9–46 U/L) | 28 (9–46 U/L) |
ALP | 73 (40–130 U/L) | 56 (36–130 U/L) | 51 (36–130 U/L) | 60 (36–130 U/L) |
Bilirubin, total | 0.6 (0.2–1.3 mg/dL) | 0.8 (0.2–1.2 mg/dL) | 0.7 (0.2–1.2 mg/dL) | 0.5 (0.2–1.2 mg/dL) |